TLR Ligand-Induced Type I IFNs Affect Thymopoiesis

Marie-Laurence Baron1, Dominique Gauchat, Ross La Motte-Mohs

  • 1Laboratoire d'Immunologie, Immunologie Humaine, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Hôpital Saint-Luc, Montréal, Québec, Canada.

Summary

Toll-like receptor (TLR) activation, particularly via TLR3 or TLR7 ligands, impairs fetal thymus development by inducing type I interferons (IFNs). This negatively impacts T cell development, a crucial consideration for vaccine adjuvant use.